New group therapy shows promise for easing anxiety and depression
NCT ID NCT06863948
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of group therapy called Terebenin's Method for adults with mild to moderate anxiety and depression. The therapy combines role-playing, body awareness, and guided discussion in weekly sessions over 8 weeks. Researchers measured changes in symptoms and stress-related biomarkers like cortisol. The goal was to see if this approach could help reduce anxiety and depression and to gather data for a larger future study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Terebenin's Method (integrative group psychotherapy combining psychodrama, systemic constellation, body-oriented practices, and directive therapy)
What this could lead to
If it works, this could offer a new group therapy option for people with mild to moderate anxiety and depression, potentially reducing symptoms and stress.
What could go wrong
This is a small pilot study with only 66 participants, so results may not apply to everyone. It's early-stage research, and the therapy may not prove more effective than standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for New Medical Technologies
Novosibirsk, 630090, Russia